The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant colon cancer: Experience in Ramon y Cajal University Hospital.
 
Olga Martinez Saez
No Relationships to Disclose
 
Arantzazu Martínez Barquín García
No Relationships to Disclose
 
Maria Villamayor Delgado
No Relationships to Disclose
 
Cristina Saavedra Serrano
No Relationships to Disclose
 
Elena Corral de la Fuente
No Relationships to Disclose
 
Juan José Serrano Domingo
No Relationships to Disclose
 
Roberto Martín Huertas
No Relationships to Disclose
 
Pablo Reguera Puertas
No Relationships to Disclose
 
FEDERICO LONGO
No Relationships to Disclose
 
Vanessa Pachon
No Relationships to Disclose
 
Mercedes Rodríguez Garrote
No Relationships to Disclose
 
Carmen Guillen
Speakers' Bureau - Bayer; Celgene; Merck Serono; Novocure; Roche Pharma AG; Sanofi/Aventis; SERVIER
Travel, Accommodations, Expenses - Celgene; Merck Serono; Roche Pharma AG; Sanofi/Aventis
 
Alfredo Carrato
Consulting or Advisory Role - Bayer; Celgene; Merck; MSD Oncology; Roche; Servier; Shire
Travel, Accommodations, Expenses - Celgene; Merck
 
Reyes Ferreiro Monteagudo
No Relationships to Disclose